Company: SRPT
Filing Date: 2025-04-24
Form Type: DEF 14A
Source: 0000950170-25-058003
Chunk: 80

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-04-24
Form: DEF 14A
Chunk 80
---
 achievement of the following:

| Milestone                                                  | Achievement Metrics and Potential Percentage of Total Award Earned                                                                               |
| Milestone One: Elevidys Label Expansion                    | Metric: Ages 4-7                                                                                                                                 
 Amount Earned: 30% Metric: Ambulatory Amount Earned: 40% Metric: Non-AmbulatoryAmount Earned: 50%                                                |
| Milestone Two: Cumulative net product revenue 2024-2025    | Metric: At least $2.7 billion Amount Earned: 30% Metric: At least $3.3 billionAmount Earned: 40% Metric: At least $4.0 billionAmount Earned: 50% |
| Milestone Three: Positive Cash Flow                        | Metric: Cumulatively over four consecutive quartersAmount Earned: 20% Metric: Cumulatively over vesting periodAmount Earned: 25%                 |
| Milestone Four: Accelerated Approval of LGMD 2E (SRP-9003) | Metric: By March 1, 2026Amount Earned: 25% Metric: By December 31, 2025Amount Earned: 31.25%                                                     |

Milestone One was achieved at the Non-Ambulatory level in the second quarter of 2024 following regulatory approval and label expansion of Elevidys in June 2024. As a result, 50% of the PSUs granted in March 2024 became earned and immediately vested on June 20, 2024.

<div align='center'>55</div>

Milestone Two, Three and Four remain fully outstanding. Milestone Two and Three must be earned, if at all, by December 31, 2025. Milestone Four must be earned, if at all, by March 1, 2026. If achieved, these three milestones also contain a time-based vesting component, and any earned PSUs under these milestones will vest on March 1, 2026, subject to the named executive officer's ongoing service to the Company.

When choosing milestones, the Board discusses with the compensation committee and senior management each of the proposed milestones. The compensation committee determines if any of the milestones have been earned and deemed "achieved" under the PSUs. Although the milestones are intended to be achievable with significant effort, we do not expect that every milestone will actually be attained or that each milestone will earn the highest percentage possible.

Section 401(k) Plan

Our Section 401(k